Abstract
Both teams expect that endothelial PAS domain protein 1 (EPAS1; HIF2A) inhibitors could treat or prevent the disease, although the researchers differ on whether HIF2A itself or an upstream activator of the transcription factor would be a better drug target. ... The normal growth of ...
Cite
CITATION STYLE
APA
Haas, M. J. (2010). HIF2A: mastering osteoarthritis. Science-Business EXchange, 3(22), 663–663. https://doi.org/10.1038/scibx.2010.663
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free